This product is only available within a bundle. You can find that bundle here.
Total Credits: .75 including .75 AOA Category 1-A Credit(s)
Title: Biomarkers for Early Detection of Alzheimer’s Disease
Presenter: Sophia Wang, M.D.
Learning Objectives
By the end of this session, participants will be able to:
1) Understand the "classical" clinical approach to diagnose mild cognitive impairment and early stage dementias using clinical assessment and neuropsychological testing.
2) Understand the A-T-N framework as the novel biological definition of Alzheimer's disease
3) Understand the appropriate use criteria for amyloid imaging and the findings of the IDEAS clinical trial.
4) Understand other novel biomarkers used for early detection for mild cognitive impairment and Alzheimer's disease.
Faculty Disclosure Declaration Statement
This presenter has no conflict of interest or disclosure to declare of any financial interest or other relationship with any commercial entities discussed in this educational presentation.
Accreditation Statement
This educational presentation was developed according to the planning, design, implementation and evaluation standards of the accreditation requirements for category 1 CME sponsors of the American Osteopathic Association (AOA). The Indiana Osteopathic Association (IOA) is accredited by the AOA to provide osteopathic continuing medical education for physicians.
Grievance Policy Statement
If you have any questions or concerns about this educational experience, you may call the IOA office at (317) 926-3009 or send an email message to info@inosteo.org. All questions or concerns will be addressed promptly.
| EarlyDetection-AD-Biomarkers Power Point (1.36 MB) | Available after Purchase | ||
Dr. Wang is an assistant professor of clinical psychiatry at Indiana University School of Medicine. She completed her M.D. degree and her general psychiatry residency at the Mount Sinai School of Medicine in New York, NY. She then pursued a neurosciences fellowship focusing on neurodegenerative disorders at the James J. Peters VAMC affiliated with the Mount Sinai School of Medicine, and a geriatric psychiatry clinical fellowship at the University of California in San Francisco, CA. Dr. Wang currently is funded on a NIA K23 Career Development Award to examine how delirium and vascular risk factors may increase the risk of long-term cognitive impairment in intensive care unit survivors. Her awards include the 2018 Beeson Travel Award and the 2018 Hartford-Jeste Award for Future Leaders in Geriatric Psychiatry from the American Psychiatric Association. She also currently serves as the Leader of the Outreach, Recruitment, and Engagement Core at the NIA funded Indiana Alzheimer Disease Center.
| 5 |
|
| 4 |
|
| 3 |
|
| 2 |
|
| 1 |
|